한화생명: directors' dealings · South Korea · DART (FSS) DART:company-993c03 KR KR · DART (FSS) Mcap 4260.4Bn€ Financial Services
Explore the full management transaction log of 한화생명, a listed equity based in South Korea. Shares are listed on KR KR, under the supervision of DART (FSS). Operating in the Financial Services sector, 한화생명 has recorded 9 insider filings. Market capitalisation: €4,260.4bn. The latest transaction was filed on 7 April 2026 (Purchase). Among the most active insiders: 김국진. All data is free.
Financial data FY ended December 2024 · cache
Analyst consensus
12 analysts 2100.00 € Target 5058.33 €(-11%) 6300.00 €
Income statement
Revenue 16656.53 Bn€
Net income 737.25 Bn€ 2.7% margin
Valuation
PER (forward) 6.0x
Beta 0.62
Balance sheet & cash
Market cap 4260.38 Bn€
Total debt 13162.38 Bn€
Free Cash Flow 5115.16 Bn€
Debt / Equity 129%
Profitability & ownership
ROE 5.9%
ROA 1.2%
% insiders 55.2%
% institutions 9.8%
Last declaration on 7 April 2026
Declarations 9 total
Executives ● Purchase5 DART
2,440,290 shares
DART:20260407002932 · 7 Apr 2026
Ideal exit: 2 Jan 2027 (T+270) Executives ● Purchase22 DART
€3,458 1,270 shares @ €2.7226 0.0000% mcap 100.0% of flow
DART:20260403001956 · 31 Mar 2026
Ideal exit: 26 Dec 2026 (T+270) Executives ● Purchase22 DART
€5,475 2,000 shares @ €2.7373 0.0000% mcap 100.0% of flow
DART:20260309001868 · 4 Mar 2026
Ideal exit: 29 Nov 2026 (T+270) Executives ● Other0 DART
DART:20260304001657 · 4 Mar 2026 details not loaded
Executives ● Mixed0 DART
DART:20210309000613 · 9 Mar 2021
Executives ● Mixed0 DART
DART:20210309000561 · 9 Mar 2021
Executives ● Other0 DART
DART:20210223003240 · 23 Feb 2021 details not loaded
Executives ● Mixed0 DART
DART:20210222002105 · 22 Feb 2021
Executives ● Mixed0 DART
DART:20210222002056 · 22 Feb 2021